Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer


Background:[18F]fluorothymidine (FLT) has been proposed as a positron emission tomography (PET)-imaging biomarker of proliferation for breast cancer. The aim of this prospective study was to assess the feasibility of FLT-PET-CT as a technique for predicting the response to neoadjuvant chemotherapy (NAC) in primary breast cancer and to compare baseline FLT… (More)
DOI: 10.1038/bjc.2014.207

7 Figures and Tables


  • Presentations referencing similar topics